Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey
- 1 January 1998
- book chapter
- Published by Springer Nature
- Vol. 52, 279-285
- https://doi.org/10.1007/978-3-7091-6499-0_28
Abstract
Striatal extracellular fluid concentrations of dopamine and metabolites in response to direct striatal administration of two L-DOPA boluses administered sequentially were determined in three rhesus monkeys during halothane anesthesia. Whereas in an initial microdialysis run, generation of dopamine was less following the second L-DOPA bolus than the first, in a subsequent run, in which the selective MAO-B inhibitor R(+)-Npropargyl-1-aminoindan (rasagiline) was administered systemically (0.2 mg/ kg s.c.) between the two L-DOPA boluses, generation of dopamine was greater following the second bolus.Keywords
This publication has 14 references indexed in Scilit:
- Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of l-DOPA-treated monkeysBrain Research, 1996
- Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian RatsJournal of Neurochemistry, 1995
- l‐3,4‐Dihydroxyphenylalanine‐Induced Dopamine Release in the Striatum of Intact and 6‐Hydroxydopamine‐Treated Rats: Differential Effects of Monoamine Oxidase A and B InhibitorsJournal of Neurochemistry, 1994
- Methodology of microdialysis of neostriatum in hemiparkinsonian nonhuman primatesExperimental Neurology, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐DeprenylJournal of Neurochemistry, 1986
- Distinct Monoamine Oxidase A and B Populations in Primate BrainScience, 1985
- SELECTIVE ACETYLENIC ‘SUICIDE’ AND REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE TYPES A AND BBritish Journal of Pharmacology, 1981
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975